verapamil has been researched along with praziquantel in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Amezcua, J; González Barranco, D; Hoyo Badillo, C; Martínez Zedillo, G | 1 |
| Aoki, Y; Matsumura, K; Sato, K; Shimada, M | 1 |
| Qian, YS; Quan, YZ | 1 |
| Hutadilok, N; Ruenwongsa, P; Yuthavong, Y | 1 |
| da Silva, SP; Noël, F | 1 |
| Lei, Z; Liu, Z; Ni, J; Wu, R; Ye, M; Zou, H | 1 |
| Abedi, S; Tabari, MA; Youssefi, MR | 1 |
1 review(s) available for verapamil and praziquantel
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for verapamil and praziquantel
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Verapamil does not block the spastic response of Praziquantel on the larvae of Taenia pisiformis.
Topics: Animals; Anthelmintics; Calcium; Drug Interactions; Larva; Muscle Contraction; Pharmaceutical Vehicles; Praziquantel; Rabbits; Solvents; Taenia; Tetany; Verapamil | 1992 |
Praziquantel-induced secretion of proteolytic enzyme from Schistosoma mansoni cercariae.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Dose-Response Relationship, Drug; Egtazic Acid; Enzyme Induction; Isoquinolines; Peptide Hydrolases; Piperazines; Praziquantel; Schistosoma mansoni; Sulfonamides; Verapamil | 1990 |
[Effects of praziquantel and its enantiomers on the physiological properties of isolated rat atria].
Topics: Animals; Female; Heart Atria; In Vitro Techniques; Male; Myocardial Contraction; Praziquantel; Rats; Stereoisomerism; Stimulation, Chemical; Verapamil | 1988 |
Stimulation of Ca2+ uptake in the human liver fluke Opisthorchis viverrini by praziquantel.
Topics: Animals; Calcimycin; Calcium; Cricetinae; Ion Channels; Isoquinolines; Kinetics; Lanthanum; Magnesium; Mesocricetus; Opisthorchis; Praziquantel; Verapamil | 1983 |
Time course of the effect of praziquantel on Schistosoma mansoni attachment in vitro: comparison with its effects on worm length and motility.
Topics: Animals; Biomphalaria; Calcium Channel Blockers; Kinetics; Male; Movement; Praziquantel; Schistosoma mansoni; Schistosomicides; Time Factors; Verapamil | 1995 |
Enantiomer separation by strong anion-exchange capillary electrochromatography with dynamically modified sulfated beta-cyclodextrin.
Topics: Anions; Atropine; beta-Cyclodextrins; Cyclodextrins; Electrophoresis, Capillary; Metoprolol; Molecular Structure; Praziquantel; Tryptophan; Verapamil | 2001 |
Pivotal role of permeability-glycoprotein in absorption of praziquantel into Dicrocoelium dendriticum parasite.
Topics: Animals; Dicrocoelium; Parasites; Permeability; Praziquantel; Sheep; Verapamil | 2023 |